224 related articles for article (PubMed ID: 10493265)
1. Review of studies of selected metabolic polymorphisms and cancer.
d'Errico A; Malats N; Vineis P; Boffetta P
IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
[No Abstract] [Full Text] [Related]
2. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
Pelkonen O; Raunio H; Rautio A; Lang M
IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
[TBL] [Abstract][Full Text] [Related]
3. A nomenclature system for metabolic gene polymorphisms.
Garte S; Crosti F
IARC Sci Publ; 1999; (148):5-12. PubMed ID: 10493244
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of cytotoxic drugs.
Daly AK; Hall AG
Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in cancer etiology and chemotherapy.
Boddy AV; Ratain MJ
Clin Cancer Res; 1997 Jul; 3(7):1025-30. PubMed ID: 9815780
[No Abstract] [Full Text] [Related]
6. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.
Lincz LF; Kerridge I; Scorgie FE; Bailey M; Enno A; Spencer A
Haematologica; 2004 May; 89(5):628-9. PubMed ID: 15136237
[TBL] [Abstract][Full Text] [Related]
7. Overall evaluation and research perspectives.
Vineis P; d'Errico A; Malats N; Boffetta P
IARC Sci Publ; 1999; (148):403-8. PubMed ID: 10493267
[No Abstract] [Full Text] [Related]
8. [Genetic polymorphism (sequence variation) of foreign substance-metabolizing enzymes and their significance in environmental medicine. Statement of the Commission "Methods and Quality Assurance in Environmental Medicine"].
Commission on Methods and Quality Assurance in Environmental Medicine
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Nov; 47(11):1115-23. PubMed ID: 15549207
[No Abstract] [Full Text] [Related]
9. Metabolic polymorphisms and cancer susceptibility.
Smith G; Stanley LA; Sim E; Strange RC; Wolf CR
Cancer Surv; 1995; 25():27-65. PubMed ID: 8718512
[TBL] [Abstract][Full Text] [Related]
10. Chapter 21. Additional polymorphisms and cancer.
Stubbins MJ; Wolf CR
IARC Sci Publ; 1999; (148):271-302. PubMed ID: 10493263
[TBL] [Abstract][Full Text] [Related]
11. [Importance of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplasms].
Niewiński P; Orzechowska-Juzwenko K
Pol Merkur Lekarski; 1997 Jan; 2(9):231-5. PubMed ID: 10907039
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
[TBL] [Abstract][Full Text] [Related]
13. [Genetic variations in the metabolism of environmental toxins].
Autrup H
Ugeskr Laeger; 2005 May; 167(20):2173-6. PubMed ID: 15987077
[No Abstract] [Full Text] [Related]
14. Glutathione S-transferases as putative host susceptibility genes for cancer risk in agricultural workers.
Eaton DL
J Biochem Mol Toxicol; 2005; 19(3):187-9. PubMed ID: 15977185
[No Abstract] [Full Text] [Related]
15. Genetic susceptibility to bladder cancer.
Taioli E; Raimondi S
Lancet; 2005 Aug 20-26; 366(9486):610-2. PubMed ID: 16112283
[No Abstract] [Full Text] [Related]
16. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphism of N-acetyltransferase-2 and pathogenesis of neoplastic diseases].
Kłodowska-Duda GA; Samelska JA; Opala GM
Wiad Lek; 2005; 58(3-4):212-7. PubMed ID: 16119167
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
19. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
20. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
